Edwards Lifesciences (EW) US TAVR Growth Well Ahead of Consensus Expectations - Jefferies
Tweet Send to a Friend
Jefferies analyst Anthony Petrone reiterated a Buy rating and $110.00 price target on Edwards Lifesciences (NYSE: EW) after data through ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
